Dexmedetomidine or Hyalase : Which of Them Can Augment Lu... | NCT05370963 | Trialant

Dexmedetomidine or Hyalase : Which of Them Can Augment Lu... | NCT05370963 | Trialant

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
hyalase group	Active Comparator	Bupivacaine 5 mg (1 mL) + Triamcinolone 40 mg (1 mL) + Saline solution (2 mL) + Hyaluronidase 1,500 IU reconstituted in 1 mL distilled water (HYL)	Drug: Hylase versus dexmedtemodine
dexmedtemodine group	Active Comparator	Bupivacaine 5 mg (1 mL) + Triamcinolone 40 mg (1 mL) + Saline solution (2 mL) + Dexmedetomidine 0.5 mic/kg	Drug: Hylase versus dexmedtemodine

Outcomes Module

Secondary Outcomes

Measure	Description	Time Frame
functional disability	Modified oswestry diability questionnaire. 0% to 20%: minimal disability:....21%-40%: moderate disability: 41%-60%: severe disability...61%-80%: crippled	6 months
acute complications